Glenmark Pharma Q2 revenue falls 30% to ₹4,247 crore, profit down 57%
Glenmark Pharmaceuticals' Q2FY27 net profit fell 56.8% to ₹263.83 crore, while revenue declined 29.8% to ₹4,247.32 crore, with earnings dragged by exceptional items.
BTC-5.31%
ETH-7.34%
SOL-6.52%
USDC+0.00%
XRP-4.90%
HYPE-7.20%
SUI-8.81%
DOGE-7.06%BTC-5.31%ETH-7.34%SOL-6.52%USDC+0.00%XRP-4.90%HYPE-7.20%SUI-8.81%DOGE-7.06%BTC-5.31%ETH-7.34%SOL-6.52%USDC+0.00%XRP-4.90%HYPE-7.20%SUI-8.81%DOGE-7.06%BTC-5.31%ETH-7.34%SOL-6.52%USDC+0.00%XRP-4.90%HYPE-7.20%SUI-8.81%DOGE-7.06%
